In clinical practice, pathological determination of the estrogen receptor (ER), progesterone receptor (PR), HER2-status (HER2), Bloom Richardson histological grade (BR) and Ki67 are generally used to determine surrogate intrinsic cancer subtypes [5]. The gene discussed is ERBB2; the disease is cancer.